XML 31 R19.htm IDEA: XBRL DOCUMENT v3.25.2
Organization and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Schedule of Accounts Receivables

Accounts receivable consist of the following:

 

   June 30, 2025   December 31, 2024 
   (Unaudited)   (Audited) 
Billed receivable  $455,152   $173,993 
Unbilled receivable   260,165    63,034 
Accounts receivable  $715,317   $237,027 
Schedule of Accounts Payable

Accounts payable consist of the following:

 

   June 30, 2025   December 31, 2024 
   (Unaudited)   (Audited) 
Research and development expenses  $654,571   $340,698 
Legal expenses       68,420 
Other   84,223    73,202 
Accounts payable  $738,794   $482,320 
Schedule of Accrued Expenses

Accrued expenses consist of the following:

 

   June 30, 2025   December 31, 2024 
   (Unaudited)   (Audited) 
Employee wages and benefits  $349,187   $496,906 
Research and development expenses   452,970    437,196 
Legal expenses   110,833    25,000 
Other   16,860    11,360 
Accrued expenses  $929,850   $970,462 
Schedule of Research and Development Costs

Research and development costs consist of personnel-related costs, facilities, research-related overhead, services from independent contract research organizations, and other external costs. Research and development costs, including related party, for the three and six months ended June 30, 2025 and 2024 were as follows:

 

   2025   2024   2025   2024 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2025   2024   2025   2024 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Outside contracted services  $486,585   $395,188   $842,841   $783,434 
Personnel related costs   124,669    106,889    246,385    213,216 
Facilities, overhead and other   18,125    13,552    35,132    41,702 
Research and development costs  $629,379   $515,629   $1,124,358   $1,038,352